Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial

BACKGROUND. We previously demonstrated the noninferiority of switching to efavirenz (EFV) versus remaining on ritonavir-boosted lopinavir (LPV/r) for virologic control in children infected with human immunodeficiency virus (HIV) and exposed to nevirapine (NVP) for prevention of mother-to-child trans...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Murnane, Pamela M., Strehlau, Renate, Shiau, Stephanie, Patel, Faeezah, Mbete, Ndileke, Hunt, Gillian, Abrams, Elaine J., Coovadia, Ashraf, Kuhn, Louise
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Major Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849095/
https://ncbi.nlm.nih.gov/pubmed/28419200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix335
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados